FECAVA 2016 – chance to share your scientific work!

Dear Colleagues,

Thank you for all the papers we have received so far!

Abstract Submission for Short Communications is open for two more weeks! Seize your chance to share your scientific work and have it published in the EJCAP Journal!

The abstract submission link is available here.

Short Communication Abstract Submission Deadline: Sunday, January 31, 2016, 12:00 GMT+1

All abstracts related to small animal medicine are eligible for submission and the 24 best abstracts (12 in internal medicine, 12 in surgery) will be selected for oral presentations. The four best oral presentations (2 in internal medicine, 2 in surgery) will receive an award of EUR 500.- during the official congress evening.

The next best 20 abstracts (10 in internal medicine, 10 in surgery) which have not been selected for oral presentation will be offered to be presented as posters.

Please also visit the FECAVA 2016 Website for up-to-date information on the scientific programme.

We look forward to receiving your scientific work and to welcoming you to Vienna in June!

Sincerely,
Dr. Manfred Hochleithner, Organizer / President VOEK

FECAVA 2016 Organizing Team Mondial Congress & Events, Mondial GmbH & Co. KG, Operngasse 20b, 1040 Vienna, Austria t + 43 1 58804-0, f–185, fecava2016@mondial-congress.com, http://www.fecava2016.org/

award of EUR 500.- during the official congress evening.
The next best 20 abstracts (10 in internal medicine, 10 in surgery) which have not been
selected for oral presentation will be offered to be presented as posters.
Please also visit the FECAVA 2016 Website for up-to-date information on the scientific
programme.
We look forward to receiving your scientific work and to welcoming you to Vienna in June!
Sincerely,
Dr. Manfred Hochleithner,
Organizer / President VOEK
FECAVA 2016 Organizing Team
Mondial Congress & Events, Mondial GmbH & Co. KG, Operngasse 20b, 1040 Vienna, Austria
t + 43 1 58804-0, f–185, fecava2016@mondial-congress.com, http://www.fecava2016.org/
If you wish not to receive further emails concerning FECAVA we apologize and would like to ask